2010•Medical InformationRequires access

A controlled analysis of the efficacy between aripiprazole and risperidone in thet reatment of patients with 236 patients of schizophrenia

Li B

Abstract

Objective:To analyse efficacy and side effect of aripiprazole of patients with schizophrenia.Methods:258 patients of schizophrenia were divider into aripiprazole group and risperidne group for the treatment of 8 weeks.The efficacy and side effect were evaluated with PANSS and TESS respectively.Results:There were no significantly differences of the between aripiprazole group and risperidne group in the treatment of the patients with schizophrenia.The side effects of aripiprazole were slighter and fewer than that of risperidone group.Conclusion:Aripiprazole has an efficacy in improving to the symptoms of patients with schizophrenia.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Aripiprazole, Risperidone, Schizophrenia (object-oriented programming), Medicine, Side effect (computer science), Internal medicine, Psychiatry, Psychology